Total Joint Arthroplasty at a Novel "Hyperspecialty" Ambulatory Surgical Center With Extended Care Suites is as Safe as Inpatient Arthroplasty.

BACKGROUND

New "hyperspecialty" ambulatory surgical centers (HASCs) have been introduced to deliver safe and cost-efficient care, allowing patients to spend additional nights in an extended care suite before discharge. This study compared the 90-day complications and readmissions of total joint arthroplasty (TJA) at an HASC and inpatient TJA at a tertiary hospital.

METHODS

We retrospectively reviewed 1365 primary, unilateral, TJAs (658 total hip arthroplasty, 707 total knee arthroplasty) performed at 4 HASCs in 2017-2021. Following their outpatient procedure, patients were discharged to an extended care suite staffed full-time by nurses and physical therapists. These patients were matched 1:1 with 1365 inpatient TJAs (628 total hip arthroplasty, 737 total knee arthroplasty) based on demographics, joint, and American Society of Anesthesiologists (ASA) score. Ninety-day complications and readmissions were compared.

RESULTS

The mean age was 60.0 ± 9.8 years and 59.4 ± 8.1 years in the inpatient and outpatient groups, respectively ( = .106). There was no difference in ASA≥3 patients (16.4% vs 17.7%;  = .387) and operative time (86.9 ± 31.8 vs 88.7 ± 27.9 minutes;  = .118). Five patients (0.4%) in the outpatient group were transferred to an acute hospital. When comparing 90-day outcomes between the inpatient and outpatient groups, there was no difference in pulmonary embolism (0.1% vs 0.0%;  = .317), mechanical complications (0.3% vs 0.7%;  = .165), periprosthetic joint infections (0.5% vs 1.1%;  = .092), or readmissions (1.2% vs 1.5%;  = .513). A subgroup analysis of ASA≥3 patients yielded similar findings.

CONCLUSIONS

Patients undergoing outpatient TJA at a novel HASC had similar complication and readmission rates as those undergoing TJA at a tertiary hospital. Based on these data, such facilities seem appropriate for the care of outpatient TJA patients with ASA<4.